TABLE OF CONTENTS
Volume 69, Issue 4 (April 2001)
Pharmacokinetics and Drug Disposition |
Pharmacodynamics and Drug Action |
Pharmacoepidemiology and Drug Utilization |
Pharmacogenetics and Genomics
Commentary
Counterfeit and substandard drugs
Marcus M. Reidenberg MD and Bradley A. Conner MD
Clin Pharmacol Ther 69: 189-193; doi:10.1067/mcp.2001.114672
Pharmacokinetics and Drug Disposition
Effects of fluconazole and fluvoxamine on the pharmacokinetics and pharmacodynamics of glimepiride
Mikko Niemi MD, Janne T. Backman MD, Mikko Neuvonen MSc, Jouko Laitila, Pertti J. Neuvonen MD and Kari T. Kivistö MD
Clin Pharmacol Ther 69: 194-200; doi:10.1067/mcp.2001.114229
A population pharmacokinetic screen to identify demographic-clinical covariates of basiliximab in liver transplantation
John M. Kovarik PhD, Björn Nashan MD, Peter Neuhaus MD, Pierre-Alain Clavien MD, Christophe Gerbeau PhD, Michael L. Hall MD and Alexander Korn PhD on behalf of the Simulect Liver Transplant Study Group
Clin Pharmacol Ther 69: 201-209; doi:10.1067/mcp.2001.114887
A population pharmacokinetic-pharmacodynamic and logistic regression analysis of lotrafiban in patients
Diane Mould PhD, Martha Chapelsky PharmD, Jagadeesh Aluri MS, James Swagzdis BS, Robert Samuels MS and Jeffrey Granett MD
Clin Pharmacol Ther 69: 210-222; doi:10.1067/mcp.2001.114925
Pharmacodynamics and Drug Action
The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: A potential mechanism for hepatic adverse reactions
Karin Fattinger MD, Christoph Funk PhD, Michael Pantze PhD, Cornelia Weber PhD, Jürg Reichen MD, Bruno Stieger PhD and Peter J. Meier MD
Clin Pharmacol Ther 69: 223-231; doi:10.1067/mcp.2001.114667
Furosemide-probenecid interaction as a laboratory exercise for undergraduate education in clinical pharmacology
Atsuhiro Kawaguchi PharmD, Koh-ichi Sugimoto MD, PhD, Masami Ohmori MD, PhD, Shuichi Tsuruoka MD, PhD, Kazuhiro Harada MD, PhD, Yasuhiko Kitoh, Eiji Kobayashi MD, PhD and Akio Fujimura MD, PhD
Clin Pharmacol Ther 69: 232-237; doi:10.1067/mcp.2001.114671
Beta-blockade with nebivolol enhances the acetylcholine-induced cutaneous vasodilation
Sandrine Kubli MD, François Feihl MD and Bernard Waeber MD
Clin Pharmacol Ther 69: 238-244; doi:10.1067/mcp.2001.114670
Specific effect of venlafaxine on single and repetitive experimental painful stimuli in humans
Thomas P. Enggaard MD, Niels A. Klitgaard PharmD, Lars F. Gram MD, Lars Arendt-Nielsen PhD and Søren H. Sindrup MD
Clin Pharmacol Ther 69: 245-251; doi:10.1067/mcp.2001.114873
Gastrin-releasing peptide is a potent vasodilator in humans
Sally Clive MRCP, Duncan Jodrell MD and David Webb MD
Clin Pharmacol Ther 69: 252-259; doi:10.1067/mcp.2001.114888
Pharmacoepidemiology and Drug Utilization
Preventing drug interactions by online prescription screening in community pharmacies and medical practices
Hillel Halkin MD, Itzhak Katzir MSc, Irena Kurman MScPharm, Joseph Jan BSc and Becky Ben-Oz Malkin MPH
Clin Pharmacol Ther 69: 260-265; doi:10.1067/mcp.2001.114228
Pharmacogenetics and Genomics
Effect of omeprazole on the pharmacokinetics of moclobemide according to the genetic polymorphism of CYP2C19
Kyung-Sang Yu MD, PhD, Dong-Seok Yim MD, PhD, Joo-Youn Cho RPh, PhD, Soon Seong Park MD, PhD, Ji Young Park MD, Kyung-Hoon Lee MD, PhD, In-Jin Jang MD, PhD, So-Young Yi RPh, MS, Kyun-Seop Bae MD, MS and Sang-Goo Shin MD, PhD
Clin Pharmacol Ther 69: 266-273; doi:10.1067/mcp.2001.114231
